Opinion

Video

TAR-200 Clinical Development Program in NMIBC

Experts briefly mention other ongoing phase 3 studies investigating TAR-200 for the treatment of non–muscle-invasive bladder cancer (NMIBC).

Video content above is prompted by the following:

  • Can you briefly mention other ongoing phase 3 studies with TAR-200?
Related Videos
Medcast series
Related Content
© 2025 MJH Life Sciences

All rights reserved.